Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis

J Cyst Fibros. 2008 Jul;7(4):307-312. doi: 10.1016/j.jcf.2007.11.006. Epub 2008 Feb 21.

Abstract

Young adults with cystic fibrosis (CF) frequently develop bone disease. One suggested aetiological factor is suboptimal vitamin K status with impaired carboxylation of osteocalcin and abnormal bone formation.

Methods: We measured bone mineralization and turnover in thirty-two 8-12 year old CF patients (14 boys) using Dual Energy X-ray absorptiometry (whole body (WB) and lumbar spine (LS)), 25-OH Vitamin D, PTH and markers of bone formation (plasma osteocalcin, N-terminal pro-peptide of type 1 collagen (P1NP)), plus an indirect measure of vitamin K status, undercarboxylated osteocalcin (uc-OC).

Results: LS bone mineral density (BMD) standard deviation (SD) scores were < -1.0 in 20% of subjects. Size-adjusted LS and WB bone mass was normal. Compared to reference data, % uc-OC was high and P1NP low. LS bone mass was predicted by % uc-OC but not other markers (0.4% decrease in size-adjusted LSBMC (p=0.05); 0.04 SD decrease in LSBMAD (p=0.04) per 1% increase in uc-OC).

Conclusion: Markers suggestive of sub-optimal vitamin K status and low bone formation were present despite normal size-adjusted bone mass. The association between LSBMC and % uc-OC is consistent with the hypothesis that sub-optimal vitamin K status is a risk factor for CF bone disease. This should ideally be investigated in an intervention trial.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 25-Hydroxyvitamin D 2 / blood
  • Absorptiometry, Photon
  • Bone Density*
  • Bone Remodeling / physiology
  • Child
  • Cohort Studies
  • Cystic Fibrosis / complications*
  • Female
  • Humans
  • Male
  • Osteocalcin / blood*
  • Osteocalcin / chemistry
  • Osteoporosis / etiology*
  • Parathyroid Hormone / blood
  • Vitamin K Deficiency / complications*

Substances

  • Parathyroid Hormone
  • Osteocalcin
  • 25-Hydroxyvitamin D 2